Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 Mar 4;17(3):e80042.
doi: 10.7759/cureus.80042. eCollection 2025 Mar.

Pericardial Effusion as the First Presentation of Systemic Lupus Erythematosus in a 22-Month-Old Infant: A Case Report and Literature Review

Affiliations
Case Reports

Pericardial Effusion as the First Presentation of Systemic Lupus Erythematosus in a 22-Month-Old Infant: A Case Report and Literature Review

Anood Al Rawahi et al. Cureus. .

Abstract

Childhood-onset systemic lupus erythematosus (cSLE) is a multi-systemic, inflammatory autoimmune disease that affects many organs including the heart. Pericardial effusion as a primary manifestation of SLE in early infancy is very rare. It has been reported as the first symptom of SLE in adult and adolescent case reports only and the youngest reported case was a three-year-old. We report a case of a 22-month-old infant who had previously been healthy but presented with pericardial effusion and a reduced ejection fraction of 20%. She progressed to cardiogenic shock and acute renal failure and required invasive ventilation, inotropic support and temporary dialysis. She was diagnosed with SLE that was genetically confirmed as autosomal recessive SLE. Her condition improved significantly after starting SLE management with immunosuppression therapy. Pericardial effusion has resolved with medical therapy only and cardiac dysfunction has recovered. According to the available literature, this is the youngest reported case of SLE manifesting as pericardial effusion. This case highlights the importance of including SLE in the differential diagnosis for infants presenting with pericarditis, myocarditis, or pericardial effusion to guide early intervention and reduce risks associated with the disease.

Keywords: immunosuppressive therapy; infant; lupus nephritis; pericardial effusion; systemic lupus erythematosus (sle).

PubMed Disclaimer

Conflict of interest statement

Human subjects: Consent for treatment and open access publication was obtained or waived by all participants in this study. The Royal Hospital Scientific Research Committee issued approval MOH/CSR/CR/25/1. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Figures

Figure 1
Figure 1. At presentation the chest X-ray shows cardiomegaly
Figure 2
Figure 2. Transthoracic echocardiography (TTE) apical four chamber and parasternal short axis 2D view showing circumferential large pericardial effusion (at the time of presentation)
Figure 3
Figure 3. Transthoracic echocardiography (TTE) parasternal short axis 2D view showing circumferential large pericardial effusion (at the time of presentation)
Figure 4
Figure 4. Chest X-ray at day five of admission shows cardiomegaly and pulmonary edema
Figure 5
Figure 5. Follow-up echocardiography after six months showing minimal pericardial effusion (apical four chamber view)
Figure 6
Figure 6. Follow-up echocardiography after six months showing minimal pericardial effusion (parasternal short axis 2D view)

References

    1. An update on the management of childhood-onset systemic lupus erythematosus. Trindade VC, Carneiro-Sampaio M, Bonfa E, Silva CA. Paediatr Drugs. 2021;23:331–347. - PMC - PubMed
    1. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Aringer M, Costenbader K, Daikh D, et al. Arthritis Rheumatol. 2019;71:1400–1412. - PMC - PubMed
    1. Systemic lupus erythematosus in children and adolescents. Levy DM, Kamphuis S. Pediatr Clin North Am. 2012;59:345–364. - PMC - PubMed
    1. Child-onset systemic lupus erythematosus is associated with a higher incidence of myopericardial manifestations compared to adult-onset disease. Chang JC, Xiao R, Mercer-Rosa L, Knight AM, Weiss PF. Lupus. 2018;27:2146–2154. - PMC - PubMed
    1. Cardiac tamponade as the first manifestation of systemic lupus erythematosus in children. Arabi MT, Malek EM, Fares MH, Itani MH. BMJ Case Rep. 2012;2012 - PMC - PubMed

Publication types

LinkOut - more resources